S264: EDIT-301 SHOWS PROMISING PRELIMINARY SAFETY AND EFFICACY RESULTS IN THE PHASE I/II CLINICAL TRIAL (RUBY) OF PATIENTS WITH SEVERE SICKLE CELL DISEASE USING HIGHLY SPECIFIC AND...

por Hanna, Rabi, Frangoul, Haydar, Mckinney, Christopher, Pineiro, Luis, Mapara, Markus, Chang, Kai-Hsin, Jaskolka, Michael, Kim, Keunpyo, Rizk, Maha, Afonja, Olubunmi, Lawal, Adebayo, Walters, Mark
Publicado 2023